類型: 連結 出處: Luxembourg Institute of Health 連結:...
admin
FDA Approves First COVID Treatment for Younger Kids
類型: 連結 作者: Molly Walker 出處: MedpageToday 連結: https://www.medpagetoday.com/infectiousdisease/covid19/98392
COVID-19 and the Brain: The Neuropathological Italian Experience on 33 Adult Autopsies
類型: PDF 作者: Viscardo P. Fabbri et al. 出處: Biomolecules 附件: PDF文件
Computational identification of Shenshao Ningxin Yin as an effective treatment for novel coronavirus infection (COVID-19) with myocarditis
Our findings reveal the pharmacological role and molecular mechanism of SNY for the treatment of COVID-19 with myocarditis. We also, for the first time, demonstrate that SNY displays multi-component, multi-target, and multi-pathway characteristics with a complex mechanism of action.
COVID Was Third Leading Cause of U.S. Deaths in 2021, Says CDC
類型: 連結 作者: Kristen Monaco 出處: MedpageToday 連結: https://www.medpagetoday.com/infectiousdisease/covid19/98375
Peripheral Muscle Fatigue Limits Post-COVID Exercise
類型: 連結 作者: Heidi Splete 出處: Medscape 連結: https://www.medscape.com/viewarticle/972512
30% of COVID Patients in Study Developed ‘Long COVID ‘
類型: 連結 作者: Ralph Ellis 出處: Medscape 連結: https://www.medscape.com/viewarticle/972536
Glasses Wearers May Have Lower COVID-19 Risk
類型: 連結 作者: Reuters Staff 出處: Medscape 連結: https://www.medscape.com/viewarticle/972248
Oral remdesivir derivative VV116 is a potent inhibitor of respiratory syncytial virus with efficacy in mouse model
類型: 連結 作者: Ruxue Zhang et al. 出處: Nature 連結: https://www.nature.com/articles/s41392-022-00963-7
Liushen Capsules, a promising clinical candidate for COVID-19, alleviates SARS-CoV-2-induced pulmonary in vivo and inhibits the proliferation of the variant virus strains in vitro
In this study, we evaluted the antiviral and anti-inflammatory activities of Liushen Capsules (LS) on different novel coronavirus in vitro, studied its therapeutic effects on novel SARS-CoV-2 infected mice and observed the LS’s clinical efficacy and safety in COVID-19.